kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance Rerouting the drug response: Overcoming
Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling KRAS OriGene Technologies Inc. Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Impact of KRAS mutation on the tumor microenvironment in colorectal cancer Overcoming resistance to drugs targeting KRASG12C mutation Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9





